Sanofi to buy Vicebio for up to US$1.6 billion in vaccine push
The French drugmaker will pay US$1.15 billion upfront with a commitment for potential milestones worth as much as US$450 millionPublished ...
The French drugmaker will pay US$1.15 billion upfront with a commitment for potential milestones worth as much as US$450 millionPublished ...
The COVID-19 vaccine by Pfizer may lead to vision loss and increase the risk of eye damage, according to a ...
Millions across the U.S. will soon no longer receive routine offers for the Covid-19 vaccine. Health and Human Services Secretary ...
US HEALTH officials are re-evaluating a US$590 million contract for bird flu shots that the Biden administration awarded to Moderna, ...
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company ...
MODERNA reported a surprise third-quarter profit on Thursday (Nov 7), driven by cost cutting and higher-than-expected sales of its Covid-19 ...
A screenshot of an alleged CNN headline has made a new claim about US vice President kamala Harris. The screenshot ...
Hillchol utilises a single, genetically engineered inactivated strain delivered that significantly reduces production costsHILLEMAN Laboratories and Indian drugmaker Bharat Biotech ...
Hillchol utilises a single, genetically engineered inactivated strain that significantly reduces production costsHILLEMAN Laboratories and Indian drugmaker Bharat Biotech have ...
Sweden has reported its first case of mpox, a day after the World Health Organization (WHO) declared the infection a ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.